Abstract: In one embodiment, the invention provides a new design of nanocarrier compositions that release their therapeutic load specifically at intraperitoneal cancers' site. These nanocarriers are administered intraperitoneally and comprise a plurality of porous nanoparticulates that (a) are loaded with one or more pharmaceutically-active agents alone or in combination with imaging agents thus providing a theranostic value and (b) that are encapsulated by and that support a lipid bilayer which is disrupted upon contact with a reactive oxygen species generated within the environment of the cancer. In other embodiments, the invention provides methods of treatment and pharmaceutical compositions comprising nanocarriers as described herein.

Abstract: The invention relates to lipid bilayer coated beads and methods of using those beads in delivery systems, in immunoassays, in analytical assays and the like.

Abstract: The invention relates to lipid bilayer coated beads and methods of using those beads in immunoassays, in analytical assay and the like.

Abstract: The invention relates to lipid bilayer coated beads and methods of using those beads in immunoassays, in analytical assay and the like.

Abstract: The invention relates to lipid bilayer coated beads and methods of using those beads in immunoassays, in analytical assay and the like.

Abstract: The present disclosure provides various novel suspended planar lipid bilayer assemblies made from bicellar mixtures containing long and short chain phospholipids and methods of making the same. Such bilayer assemblies may additionally incorporate biomolecules such as proteins, polypeptides, biological complexes, transmembrane proteins and other membrane-associated compounds. The present disclosure further provides uses for such lipid bilayer assemblies including proteomics, membrane study, biosensing for medical diagnosis and environmental monitoring, chemical and biological warfare agent sequestration, actuator development, and bio-fuel cell development.